Ling-Chuan Guo (Lingchuan Guo)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Top Venues

Experimental biology and medicine (Maywood, N.J.)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yinyin Shu, Xiaoni Jin, Mintao Ji, Zhisen Zhang, Xiuxiu Wang, Haisheng Liang, Shuangshuang Lu, Shuai Dong, Yiping Lin, Yuhan Guo, Qiuyu Zhuang, Yuhong Wang, Zhe Lei, Ling-Chuan Guo, Xuan-Yu Meng, Guangming Zhou, Wensheng Zhang, Lei Chang
Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis. Cancer research (2024)
Wei Wang, Yun Gu, Hao Ni, Qiuying Quan, Ling-Chuan Guo
Silencing of FAM111B inhibits tumor growth and promotes apoptosis by decreasing AKT activity in ovarian cancer. Experimental biology and medicine (Maywood, N.J.) (2023)
Wei Wang, Yun Gu, Hao Ni, Qiuying Quan, Ling-Chuan Guo
Silencing of FAM111B inhibits tumor growth and promotes apoptosis by decreasing AKT activity in ovarian cancer. Experimental biology and medicine (Maywood, N.J.) (2023)
Wei Wang, Yun Gu, Hao Ni, Qiuying Quan, Ling-Chuan Guo
Silencing of FAM111B inhibits tumor growth and promotes apoptosis by decreasing AKT activity in ovarian cancer. Experimental biology and medicine (Maywood, N.J.) (2023)
Xiao-Shun He, Wen-Long Ye, Yu-Juan Zhang, Xiao-Qin Yang, Feng Liu, Jing-Ru Wang, Xiao-Lu Ding, Yun Yang, Ruo-Nan Zhang, Yuan-Yuan Zhao, Hai-Xia Bi, Ling-Chuan Guo, Wen-Juan Gan, Hua Wu
Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling. Oncogene 41 (8) (2022)